CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase I/II Trial of Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for B-cell Leukemias
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06364423
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:19.231961+00:00
- Published At
- 2026-03-02T00:00:00+00:00
- Record Updated At
- 2026-03-02
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Leukemia, Lymphocytic, Chronic, B-Cell", "B-Lymphocytic Leukemia, Chronic", "B-Cell Chronic Lymphocytic Leukemia", "Acute Lymphoblastic Leukemia", "Lymphoblastic Lymphoma", "Leukemia, Acute Lymphoblastic", "Small Lymphocytic Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-02"- protocolSection.identificationModule.nctId
"NCT06364423"- protocolSection.identificationModule.officialTitle
"Phase I/II Trial of Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for B-cell Leukemias"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.